Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK Profile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03610867
What this trial is testing

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349

Who this might be right for
Healthy Chinese Volunteers
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 64
Early research (Phase 1)Study completedNCT00854113
What this trial is testing

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

Who this might be right for
Safety and Tolerability of EGT0001474 in Healthy Volunteers
Theracos 78
Early research (Phase 1)Study completedNCT04318743
What this trial is testing

A Bridging Trial to Compare the PK Profile When Glepaglutide is Administered Via Vial/Syringe Versus Autoinjector.

Who this might be right for
Healthy
Zealand Pharma 85
Early research (Phase 1)Study completedNCT05148312
What this trial is testing

Single-dose AQ001S PK Study in Healthy Volunteers

Who this might be right for
Pharmacokinetics
Aquilon Pharmaceuticals S.A. 29
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Early research (Phase 1)UnknownNCT02579473
What this trial is testing

Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Who this might be right for
Parkinson's Disease
Serina Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT00778518
What this trial is testing

Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).

Who this might be right for
Growth Hormone Deficiency
Ambrx, Inc. 36
Early research (Phase 1)Study completedNCT00728832
What this trial is testing

A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery

Who this might be right for
Postoperative Pain
EKR Therapeutics, Inc 39
Early research (Phase 1)Study completedNCT06044467
What this trial is testing

The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects

Who this might be right for
Nonalcoholic Fatty Liver Disease
ChemomAb Ltd. 16
Early research (Phase 1)Study completedNCT06178718
What this trial is testing

Evaluate PK Profile and Food Effects on PK Parameters of TNP-2092 Capsules

Who this might be right for
Hyperammonemia
TenNor Therapeutics (Suzhou) Limited 58
Early research (Phase 1)Study completedNCT02283190
What this trial is testing

1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Ashkan Emadi 5
Testing effectiveness (Phase 2)Ended earlyNCT00787618
What this trial is testing

Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females

Who this might be right for
Renal Impairment
Repros Therapeutics Inc. 6
Early research (Phase 1)Active Not RecruitingNCT07160335
What this trial is testing

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

Who this might be right for
Non-small Cell Lung CancerMelanomaRenal Cell Carcinoma
Shanghai Henlius Biotech 174
Early research (Phase 1)Not Yet RecruitingNCT07408908
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus Erythematosus
Xiamen Amoytop Biotech Co., Ltd. 48
Early research (Phase 1)Study completedNCT04120233
What this trial is testing

MW151-101: First-in-human Study of MW151

Who this might be right for
Drug Toxicity
Linda Van Eldik 40
Early research (Phase 1)UnknownNCT03975010
What this trial is testing

Buprenorphine Transdermal Patches Pharmacokinetic Study

Who this might be right for
Chronic Pain
Mundipharma (China) Pharmaceutical Co. Ltd 45
Early research (Phase 1)Study completedNCT00741273
What this trial is testing

Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults

Who this might be right for
Impaired Liver Function
Repros Therapeutics Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01623466
What this trial is testing

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

Who this might be right for
Healthy
Agile Therapeutics 36
Early research (Phase 1)Study completedNCT04327765
What this trial is testing

Staccato® Granisetron Multiple Dose PK

Who this might be right for
Healthy
Alexza Pharmaceuticals, Inc. 30
Very early researchStudy completedNCT00602914
What this trial is testing

A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle

Who this might be right for
Intradermal Injections
NanoPass Technologies Ltd 23
Next Page